Tummalapalli, Sri Lekha

Chronic kidney disease and the global public health agenda: an international consensus

Francis, A., Harhay, M. N., Ong, A. C. M., Tummalapalli, S. L., Ortiz, A., Fogo, A. B., Fliser, D., Roy-Chaudhury, P., Fontana, M., Nangaku, M., et al. (2024) · Nature Reviews Nephrology

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 1,374

The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Shlipak, M. G., Tummalapalli, S. L., Boulware, L. E., Grams, M. E., Ix, J. H., Jha, V., Kengne, A.-P., Madero, M., Mihaylova, B., Tangri, N., et al. (2021) · Kidney International

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 581

Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System

Lamprea-Montealegre, J. A., Madden, E., Tummalapalli, S. L., Peralta, C., Neilands, T. B., Garcia, P. K., Muiru, A., Karliner, L., Shlipak, M. G., & Estrella, M. M. (2022) · JAMA

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 129

Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types

Tummalapalli, S. L., Montealegre, J. L., Warnock, N., Green, M., Ibrahim, S. A., & Estrella, M. M. (2021) · JAMA Health Forum

Diabetes Treatment and ManagementPharmaceutical Economics and Policy

Cited by 42